Treatment Therapies in Pancreatic Carcinoma
Pancreatic cancer is the fourth leading cause of cancer deaths, being responsible for 7% of all cancer-related deaths in both men and women. Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occurs in the body of the pancreas, and 5-10% occurs in the tail. Scientists are learning more about some of the changes in DNA that cause cells in the pancreas to become cancerous. Inherited changes in genes such as BRCA2, p16, and the genes responsible for hereditary non-polyposis colorectal cancer (HNPCC) can increase a person’s risk of developing pancreatic cancer.
- Proton therapy
- Radiation therapy
- Chemotherapy
- Immunotherapy
- Ablation or embolization treatments
Related Conference of Treatment Therapies in Pancreatic Carcinoma
July 06-07, 2026
9th International Conference on Digestive and Metabolic Diseases
Amsterdam, Netherlands
August 25-26, 2026
18th World Conference on Gynecology, Obstetrics and Women Health
Barcelona, Spain
September 07-08, 2026
26th International Conference on Gastroenterology and Hepatology
Edinburgh, Scotland
October 19-20, 2026
25th International Conference on Gastroenterology and Digestive Disorders
Rome, Italy